Dietary Amino Acid Supplementation Research Articles

383 Performance of piglets in response to graded dietary supplementation of sulfur amino acids using either hydroxy-methionine or DL-Methionine during the post-weaning period

Abstract Providing piglets with their precise nutritional need is critical during the stressful post-weaning period. Methionine (Met), a sulfur-containing amino acid, has a crucial role in piglet growth and health. Stressful conditions may increase Met demand due to its involvement in maintaining redox balance via downstream metabolites such as glutathione. There are different sources of supplementary Met for pigs such as DL-methionine (DL-Met) and hydroxy-methionine. The latter comes mostly as an acidic liquid form (OH-Met) and to a lesser degree as a powder calcium-salt (OH-Met-Ca). This study investigates the effect of graded levels of dietary total sulfur amino acids (TSAA) by supplementing different sources of Met on the performance and capacity of post-weaning piglets to respond to stress. Two experiments were performed. In experiment 1, post-weaning piglets [n = 90; 28 d of age; body weight (BW) = 9.13 ± 0.65 kg] were fed with either DL-Met or OH-Met-Ca to provide 80%, 100%, and 125% TSAA recommendations of NRC and performance parameters were measured for 41 d. Treatments were replicated nine times, and blocking was done according to initial BW. For experiment 2, 720 post-weaning piglets (n = 720; 28 d of age; BW = 6.84 ± 1.07 kg) from three consecutive breeding batches were fed with either DL-Met, OH-Met, or OH-Met-Ca at or above (100% or 125%) TSAA requirements of FEDNA. Performance parameters and oxidative status through various plasma indicators were measured. Treatments were replicated 12 times. Data from both experiments were analyzed separately using a mixed effect model with Met source and level as fixed effects (and their interaction in experiment 2) and blocks and batch as random effects for experiments 1 and 2, respectively. In experiment 1, piglets fed 80% of TSAA requirement showed the least average daily weight gain, while those fed OH-Met-Ca at 100% or DL-Met at 125% requirement had the greatest BW gain among the treatments (P < 0.01). Feed conversion ratio was best for piglets fed with OH-Met-Ca at 100% requirement, while animals fed with 80% requirement were the least efficient (P = 0.04). Contrasts showed no differences between Met sources (P ≥ 0.51) and level of TSAA (P ≥ 0.56) for any of the parameters. Meanwhile in experiment 2, there were no interactions between Met source and TSAA level (P > 0.10). The Met source did not affect any parameter (P ≥ 0.14). However, there was a significant decrease in daily feed intake when piglets were fed above requirements (P = 0.02), and a significant increase in the concentration of plasma glutathione peroxidase when piglets were fed at TSAA requirements (P < 0.05). These results suggest that post-weaning piglet performance and oxidative status can be sustained regardless of the Met source tested. Feeding healthy and unchallenged piglets with excess dietary Met may not bring extra benefits.

Health economic impact of patients with phenylketonuria (PKU) in France – A nationwide study of health insurance claims data

BackgroundPhenylketonuria (PKU) is an inherited metabolic disease. If left untreated, it can lead to severe irreversible intellectual disability and can cause seizures, behavior disturbance, and white matter disease. This study aimed at evaluating the health economic impact of patients with PKU in France. MethodsThis retrospective observational study used health insurance claims data from the French SNDS (Système National des Données de Santé) database, which contains data from over 66 million French inhabitants. Patients with PKU were identified by ICD-10 diagnosis codes E70.0 (PKU) and E70.1 (Other hyperphenylalaninemia) documented as a chronic condition (affection de longue durée – ALD) or in the inpatient setting in the SNDS database between 2006 and 2018. Patients with PKU were matched to controls without PKU by age, sex, and region. Patients with early- and late-diagnosed PKU were defined as patients born after and before the implementation of nationwide newborn screening in France in 1972, respectively. Outcomes were analyzed for the year 2018. ResultsOverall, 3549 patients with PKU were identified in the database on January 1st, 2018. Of those, 3158 patients versus 15,703 controls with at least one healthcare consumption in 2018 were available for outcome analyses. Patients with PKU had 7.7 times higher healthcare costs than non-PKU controls in 2018 (€11,144 versus 1456 mean costs; p < 0.0001). Pharmaceutical costs including dietary amino acid supplements were the cost driver and contributed 80.0% of the overall mean difference (MD) between patients with PKU and matched non-PKU controls. More than half (52.4%) of the mean pharmaceutical costs per patient with PKU was attributable to medical foods including dietary amino acid supplements.Of the 3158 patients with PKU, 2548 (80.7%) were classified as early-diagnosed and 610 (19.7%) as late-diagnosed. Increased healthcare costs, in comparison to non-PKU controls, were more evident in early-diagnosed patients (€11,263 versus €855 mean costs; 13.2-fold increase; p < 0.0001). For patients with late-diagnosed PKU, healthcare costs were 2.7-fold higher compared to matched non-PKU controls (€10,644 versus €3951 mean costs; p < 0.0001). Outpatient pharmaceutical costs accounted for 89.1% of the MD between early-diagnosed patients and controls. Among late-diagnosed patients, 55.5% of the MD were attributable to costs for inpatient care, followed by costs for outpatient care (23.9%) and outpatient pharmaceutical costs (20.6%). ConclusionThe results indicate that PKU is associated with substantially increased health care costs compared to non-PKU controls in France. The health economic impact was most evident in patients with early-diagnosed PKU due to increased outpatient pharmaceutical costs, especially for medical foods including dietary amino acid supplements. For late-diagnosed and by definition older patients with PKU, the excess costs compared with matched controls were mostly driven by costs for inpatient care.

Role of dietary nutrients and metabolism in colorectal cancer.

Colorectal cancer (CRC) is one of the most common malignancies and the leading causes of cancer related deaths worldwide. The development of CRC is driven by a combination of genetic and environmental factors. There is growing evidence that changes in dietary nutrition may modulate the CRC risk, and protective effects on the risk of developing CRC have been advocated for specific nutrients such as glucose, amino acids, lipid, vitamins, micronutrients and prebiotics. Metabolic crosstalk between tumor cells, tumor microenvironment components and intestinal flora further promote proliferation, invasion and metastasis of CRC cells and leads to treatment resistance. This review summarizes the research progress on CRC prevention, pathogenesis, and treatment by dietary supplementation or deficiency of glucose, amino acids, lipids, vitamins, micronutri-ents, and prebiotics, respectively. The roles played by different nutrients and dietary crosstalk in the tumor microenvironment and metabolism are discussed, and nutritional modulation is inspired to be beneficial in the prevention and treatment of CRC.

PSVI-7 A traceable signature for a recovery microbiome composition after a dysbiosis caused by a sanitary challenge in pigs

Abstract Recent insights continue to point to a causal role of the gastrointestinal (GI) microbiome in digestion, nutrient absorption, and host metabolism. The GI microbiome may be a frequent target of perturbation since some challenges (i.e., high density, temperature and air quality fluctuations, presence of endemic enteric pathogens) faced by pigs may altogether create a spectrum of contrasting sanitary conditions. Therefore, our study investigated the influence of increased dietary tryptophan, threonine, and methionine supplementation in pigs from “good” vs. “poor” sanitary conditions, on the GI microbiome over time. For that purpose, female growing pigs were randomly assigned in a 2 × 2 factorial design (n = 30/treatment), consisting of two sanitary conditions (“good” vs. “poor”) and two diets [control (CN) vs. supplemented with specific amino acids (Trp, Thr, and Met+Cys:Lys ratios increased to 20% greater than CN]. Pigs allocated to the “good” sanitary condition treatment were sham-inoculated with pure BHI broth and the barn was cleaned twice a day and disinfected once a week. Whereas, “poor” sanitary condition comprised of all pigs being inoculated with 2 x 109 CFU of Salmonella Typhimurium (ST), in addition to spreading fecal material from a commercial farm under sanitary challenge, followed by leaving the barn uncleaned throughout the study (poor + ST). Fecal samples (n = 11) were collected at day post-challenge (DPC) 0, 10, and 21, and were sequenced for 16S rRNA data analysis of community diversity (alpha and beta) and taxonomic changes over time. Our results demonstrated that both alpha (Shannon and Simpson) and beta diversity metrics were significantly altered at DPC 21 by differentiating “good” vs “poor + ST” treatments, despite amino acids supplementation in the diet. Bacterial taxonomic analysis further captured community level alterations by a marked dysbiosis occurring on pigs allocated under “poor + ST” sanitary conditions. “ST + poor” sanitary conditions altered community structure as measured by co-occurrence networks, which was particularly pointed out at DPI 21. Specifically, Clostridium sensu stricto 1, Intestinibacter, Rombustsia, Terrisporobacter, and Megasphaera were five taxa between others co-enriched in fecal samples from pigs allocated under “poor + ST” sanitary conditions at DPC 21. These putative SCFA-producing bacteria were positively straighter correlated between them (Figure 1), which suggests a traceable signature for a recovery microbiome composition after a dysbiosis. In conclusion, temporal changes in fecal swine microbiome of growing pigs may be reflective of sanitary status despite dietary supplementation of specific amino acids.

Evaluation of Dietary Essential Amino Acid Supplementation on Growth, Digestive Capacity, Antioxidant, and Intestine Health of the Juvenile Redclaw Crayfish, Cherax quadricarinatus.

The present study was an 8-week feeding trial investigating the effects of lysine and threonine supplementation in vegetable-based diets on growth, antioxidative capacity, and gut microbiota of juvenile redclaw crayfish, Cherax quadricarinatus (initial weight 11.52 ± 0.23 g). The lysine and threonine were supplemented to formulate five isonitrogenous (37%) and isolipidic (9%) diets containing 0% (control), 0.2% lysine (L0.2), 0.2% threonine (T0.2), 0.4% lysine (L0.4), and 0.4% threonine (T0.4), respectively. Compared to the control, weight gain rate (WGR) and specific growth rate (SGR) of C. quadricarinatus significantly increased with increasing dietary lysine and threonine supplementation from 0.2% to 0.4% (P < 0.05). Hepatopancreas trypsin activity significantly increased with increasing levels of lysine and threonine in diets (P < 0.05). However, the pepsin, lipase, and amylase activities were not affected by dietary levels of lysine and threonine (P > 0.05). Compared with the control, crayfish in T0.4 and L0.4 showed significantly higher glutathione peroxidase (GPx) activity (P < 0.05), lower alanine aminotransferase (ALT) activity, and lower malondialdehyde (MDA) content (P < 0.05). Supplementation with 0.4% lysine significantly changed the composition of the gut microbiota (P < 0.05), which showed a significantly increased relative abundance of Proteobacteria and decreased Firmicutes, Actinomycetes, and Pontomyces (P < 0.05). The PICRUSt analysis demonstrated that the abundance of the metabolism and cellular processes pathways in the L0.4 group were markedly decreased compared with the control (P < 0.05). Meanwhile, a tighter interaction of the microbiota community in crayfish was observed in the T0.4 experimental group. In conclusion, these results suggested that dietary supplementation with 0.4% threonine could significantly promote growth and improve microbial health in juvenile C. quadricarinatus.

Health status and comorbidities of adult patients with late-diagnosed phenylketonuria (PKU) born before the newborn screening in France – A nationwide study of health insurance claims data

BackgroundPhenylketonuria (PKU) is an inborn error of metabolism. When diagnosed late, it causes developmental delay or severe irreversible intellectual disability. This study aimed at evaluating the health status and healthcare consumption of late-diagnosed PKU patients in France. MethodsThis retrospective observational study used health insurance claims data from the French SNDS (Système National des Données de Santé) database, which contains data from over 66 million French inhabitants. Patients with PKU were identified between 2006 and 2018 by ICD-10 diagnosis codes E70.0 / E70.1 documented as a chronic condition (affection de longue durée – ALD) or in the inpatient setting. Patients with PKU were matched to controls by age, sex, and region. Patients with late-diagnosed PKU were defined as patients born before the nationwide implementation of newborn screening in France in 1972. Outcomes were analyzed for the year 2018. ResultsIn total, 3549 patients with PKU were identified in the database on January 1st, 2018. Of those, 3469 patients could be matched to 17,170 controls without PKU. Of these, 2175 patients were at least 16 years old of whom 647 patients were categorized as late-diagnosed. The late-diagnosed PKU patients suffered significantly more often from hypertension (60.9% vs. 50.4%, p < 0.0001), hypercholesterolemia (41.7% vs. 26.9%, p < 0.0001), diabetes (24.4% vs. 14.1%, p < 0.0001), depression (20.6% vs. 13.8%, p < 0.0001), ischemic heart disease (16.1% vs. 6.6%, p < 0.0001), obesity (7.9% vs. 2.5%, inpatient diagnoses only, p < 0.0001), and chronic kidney disease (5.2% vs. 1.3%, inpatient diagnoses only, p < 0.0001) compared with their non-PKU controls. Consequently, significantly more patients with late-diagnosed PKU received medication to treat comorbidities associated with the nervous (82.6% vs 77.0%; p = 0.0021) and cardiovascular system (69.5% vs 58.0%; p < 0.0001). Overall, only 3.4% of patients with late-diagnosed PKU received dietary amino-acid supplements and 0.7% received sapropterin. ConclusionThe results indicate that PKU is associated with a significantly higher risk of comorbidities along with increased pharmaceutical prescriptions in patients with late-diagnosed PKU, compared with non-PKU controls. The increased risk of comorbidities was more pronounced than in patients with early-diagnosed PKU, as shown in previous research, but these patients are older than those with early-diagnosed PKU. Only few late-diagnosed patients were treated specifically for PKU. Patients with late-diagnosed PKU should be referred to specialized centers to prevent and manage comordities and introduce PKU-specific treatment when it is possible.

Impact of Dietary Protein on the Management of Pediatric Short Bowel Syndrome.

Essential amino acids (AAs) play a key role in stimulating intestinal adaptation after massive small gut resection. The nutritional effect of dietary amino acids during intestinal regrowth has received considerable attention in recent years. This review explores the significance of dietary amino acids in the nutritional management of infants and children with intestinal failure and short bowel syndrome (SBS) as reported in the medical literature over the last three decades. A literature search was conducted using electronic databases. Breast milk emerged as the first-line enteral regimen recommended for infants with SBS. Hydrolyzed formulas (HFs) or amino acid formulas (AAFs) are recommended when breast milk is not available or if the infant cannot tolerate whole protein milk. The superiority of AAFs over HFs has never been demonstrated. Although glutamine (GLN) is the main fuel for enterocytes, GLN supplementation in infants with SBS showed no difference in the child's dependence upon parenteral nutrition (PN). Circulating citrulline is considered a major determinant of survival and nutritional prognosis of SBS patients. Early enteral nutrition and dietary supplementation of AAs following bowel resection in children are essential for the development of intestinal adaptation, thereby eliminating the need for PN.

Role of amino acid metabolism in mitochondrial homeostasis.

Mitochondria are central hubs for energy production, metabolism and cellular signal transduction in eukaryotic cells. Maintenance of mitochondrial homeostasis is important for cellular function and survival. In particular, cellular metabolic state is in constant communication with mitochondrial homeostasis. One of the most important metabolic processes that provide energy in the cell is amino acid metabolism. Almost all of the 20amino acids that serve as the building blocks of proteins are produced or degraded in the mitochondria. The synthesis of the amino acids aspartate and arginine depends on the activity of the respiratory chain, which is essential for cell proliferation. The degradation of branched-chain amino acids mainly occurs in the mitochondrial matrix, contributing to energy metabolism, mitochondrial biogenesis, as well as protein quality control in both mitochondria and cytosol. Dietary supplementation or restriction of amino acids in worms, flies and mice modulates lifespan and health, which has been associated with changes in mitochondrial biogenesis, antioxidant response, as well as the activity of tricarboxylic acid cycle and respiratory chain. Consequently, impaired amino acid metabolism has been associated with both primary mitochondrial diseases and diseases with mitochondrial dysfunction such as cancer. Here, we present recent observations on the crosstalk between amino acid metabolism and mitochondrial homeostasis, summarise the underlying molecular mechanisms to date, and discuss their role in cellular functions and organismal physiology.

The Effects of Sugar Syrup Enriched with Amino Acid Mixtures at Different Concentrations on Colony Population Dynamics and Development Characteristics of Bumble bee (Bombus terrestris)

In this study, we tested the effects of amino acid-supplemented diets on colony development performances in Bombus terrestris. A total of 75 queens artificially hibernated were randomly separated into three groups. These groups were fed with different diets: normal sugar syrups and normal pollen (Control), sugar syrup which contains recommended dose (for honey bees: 10 mL/L, Sucrose syrup) of amino acid supplement and normal pollen (10 mL/L), sugar syrup which contains twice higher recommended dose of amino acid supplement and normal pollen (20 mL/L). Some developmental traits of queens and their colonies were determined. According to our findings, there were no significant differences in any of the traits of colony development except the number of total individuals among the groups (P&lt;0.05). Results showed that feeding with an amino acid-supplemented diet is not influencial on colony development traits in B. terrestris.

Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss

Glucagon analogs show promise as components of next-generation, multi-target, anti-obesity therapeutics. The biology of chronic glucagon treatment, in particular, its ability to induce energy expenditure and weight loss, remains poorly understood. Using a long-acting glucagon analog, G108, we demonstrate that glucagon-mediated body weight loss is intrinsically linked to the hypoaminoacidemia associated with its known amino acid catabolic action. Mechanistic studies reveal an energy-consuming response to low plasma amino acids in G108-treated mice, prevented by dietary amino acid supplementation and mimicked by a rationally designed low amino acid diet. Therefore, low plasma amino acids are a pre-requisite for G108-mediated energy expenditure and weight loss. However, preventing hypoaminoacidemia with additional dietary protein does not affect the ability of G108 to improve glycemia or hepatic steatosis in obese mice. These studies provide a mechanism for glucagon-mediated weight loss and confirm the hepatic glucagon receptor as an attractive molecular target for metabolic disease therapeutics.

Formulating Diets for Improved Health Status of Pigs: Current Knowledge and Perspectives.

Simple SummaryToday’s swine production systems are mostly intensive, and pigs are continuously exposed to pathogens and immune stimulatory antigens that may negatively impact productivity. It is known that immune system stimulation may reduce appetite, growth, and nutrient use efficiency compared to healthy animals. On the other hand, there is progressive pressure towards the reduction in antibiotic usage in livestock production, which highlights the need for furthering our understanding of the relationship between nutrition and the immune response. Swine nutritionists will need to consider the role of nutrition on health in order to develop programs that support production and robustness of pigs under a variety of stressful conditions. Among the nutritional strategies whose utilization may directly impact on the immune status of pigs, feeding low protein, amino acid-supplemented diets, supplementation of functional amino acids, dietary fiber level and source, diet complexity, organic acids, and plant secondary metabolites are at the forefront. As such, this review will discuss the impact of immune status on swine production and the interaction between nutrients and animal health, focusing on the roles of each nutritional strategy during times of immune challenge.Our understanding of nutrition has been evolving to support both performance and immune status of pigs, particularly in disease-challenged animals which experience repartitioning of nutrients from growth towards the immune response. In this sense, it is critical to understand how stress may impact nutrient metabolism and the effects of nutritional interventions able to modulate organ (e.g., gastrointestinal tract) functionality and health. This will be pivotal in the development of effective diet formulation strategies in the context of improved animal performance and health. Therefore, this review will address qualitative and quantitative effects of immune system stimulation on voluntary feed intake and growth performance measurements in pigs. Due to the known repartitioning of nutrients, the effects of stimulating the immune system on nutrient requirements, stratified according to different challenge models, will be explored. Finally, different nutritional strategies (i.e., low protein, amino acid-supplemented diets; functional amino acid supplementation; dietary fiber level and source; diet complexity; organic acids; plant secondary metabolites) will be presented and discussed in the context of their possible role in enhancing the immune response and animal performance.

Effects of dietary branched-chain amino acid supplementation on serum and milk metabolome profiles in dairy cows during early lactation.

The 3 branched-chain AA (BCAA), Val, Leu, and Ile, are essential AA used by tissues as substrates for protein synthesis and energy generation. In addition, BCAA are also involved in modulating cell signaling pathways, such as nutrient sensing and insulin signaling. In our previous study, dietary BCAA supplementation was shown to improve protein synthesis and glucose homeostasis in transition cows. However, a more detailed understanding of the changes in metabolic pathways associated with an increased BCAA availability is desired to fine-tune nutritional supplementation strategies. Multiparous Holstein cows (n = 20) were enrolled 28 d before expected calving and assigned to either the BCAA treatment (n = 10) or the control group (n = 10). Cows assigned to BCAA were fed 550 g/d of rumen-protected BCAA mixed with 200 g/d of dry molasses from calving until 35 DIM, whereas the cows assigned to the control were fed only 200 g/d of dry molasses. Serum samples were collected on d 10 before expected calving, as well as on d 4 and d 21 postpartum. Milk samples were collected on d 14 postpartum. From a larger cohort, we selected 20 BCAA-supplemented cows with the greatest plasma urea nitrogen concentration, as an indicator for greater BCAA availability, for the metabolomics analysis herein. Serum and milk samples were subjected to a liquid chromatography-mass spectrometry-based assay, detecting and measuring the abundance of 241 serum and 211 milk metabolic features, respectively. Multivariable statistical analyses revealed that BCAA supplementation altered the metabolome profiles of both serum and milk samples. Increased abundance of serum phosphocholine and glutathione and of milk Val, Ile, and Leu, and decreased abundance of milk acyl-carnitines were associated with BCAA supplementation. Altered phosphocholine and glutathione abundances point to altered hepatic choline metabolism and antioxidant balance, respectively. Altered milk acyl-carnitine abundances suggest changes in mammary fatty acid metabolism. Dietary BCAA supplementation was associated with a range of alterations in serum and milk metabolome profiles, adding to our understanding of the role of BCAA availability in modulating dairy cow protein, lipid, and energy metabolism on a whole-body level and how it affects milk composition.

Additional supplementation of sulfur-containing amino acids in the diets improves the intestinal health of turbot fed high-lipid diets

An eight-week feeding trial was conducted to investigate the effects of diets supplemented with three sulfur-containing amino acids (SAA), namely, methionine, cysteine, and taurine, on the intestinal health status of juvenile turbot (Scophthalmus maximus) fed high-lipid diets. Four diets were formulated, namely, a high-lipid control diet (16% lipid, HL) and three SAA-supplemented diets, which were formulated by supplementing 1.5% methionine (HLM), 1.5% cysteine (HLC), and 1.5% taurine (HLT) into the HL control diet, respectively. Each diet was assigned to triplicate tanks, and each tank was stocked with 30 juvenile fish (appr. initial weight, 8 g). The histological and morphometric results showed that dietary SAA supplementation obviously improved the intestinal morphology and integrity, in particular as reflected by higher height of microvilli and mucosal folds. Dietary SAA supplementation, in particular cysteine, up-regulated the gene expression of mucin-2 and tight junction proteins (ZO-1, Tricellilun and JAM). Dietary SAA supplementation remarkably down-regulated the gene expression of apoptosis-related factors such as p38, JNK, and Bax, expression of pro-inflammatory factors (e.g., NF-κB, AP-1 IL-1β, IL-8, and TNF-α). SAA supplementation resulted in higher antioxidative abilities in the intestine. Additionally, dietary SAA supplementation largely altered the communities of intestinal microbiota. Compared with the HL group, higher relative abundance of potential beneficial bacteria, and lower relative abundance of opportunistic pathogens were observed in SAA-supplemented groups. Dietary taurine supplementation significantly increased the relative abundance of Ligilactobacillus (in particular Lactobacillus murinus) and Limosilactobacillus (especially Lactobacillus reuteri). In conclusion, dietary sulfur-containing amino acids supplementation have promising potential in ameliorating the intestinal inflammation of turbot fed high-lipid diets. Especially dietary cysteine and taurine supplementation have more positive effects on the communities of the intestinal microbiota of turbot.

The effect of dietary protein level and amino acid supplementation on the Nile tilapia (Oreochromis niloticus) nursering performance under biofloc system conditions at a cold suboptimal water temperature

The effect of dietary protein level and amino acid supplementation on the Nile tilapia (Oreochromis niloticus) nursering performance under biofloc system conditions at a cold suboptimal water temperature

Dietary supplementation of sulfur amino acids improves intestinal immunity to Eimeria in broilers treated with anti-interleukin-10 antibody.

Oral antibody to interleukin-10 (anti-IL-10) enhances the intestinal immune defense against Eimeria. The sulfur amino acids methionine and cysteine (M+C) play essential roles in inducing and maintaining protective immune responses during intestinal infections. Hence, increased dietary M+C may support the anti-IL-10-induced intestinal immunity to Eimeria. Broilers (n = 640) were arranged in a 2 × 2 × 2 factorial design with 2 levels of each of the 3 main factors: dietary standardized ileal digestible (SID) M+C levels (0.6% or 0.8%), dietary anti-IL-10 supplementation (with or without), and coccidiosis challenge (control or challenge). Briefly, the broilers were supplied with either 0.6% or 0.8% SID M+C, each with or without anti-IL-10 (300 μg/kg), from d 10 to 21. On d 14, broilers from each diet were gavaged with either PBS or Eimeria. The resulting Eimeria infection induced fecal oocyst shedding and intestinal lesions. Broilers fed 0.8% SID M+C (main effects, P ≤ 0.05) had decreased feed-to-gain ratio, increased duodenum and cecum luminal anti-Eimeria IgA titers, and decreased fecal oocyst counts, when compared to 0.6% SID M+C. The supplementation of anti-IL-10 (main effects, P ≤ 0.05) increased cecum luminal total IgA concentration and decreased cecum lesions. Interactions (P ≤ 0.05) were detected for growth performance and cecum luminal IFN-γ. Briefly, the highest body weight gain and feed intake were reached in PBS-gavaged broilers fed 0.8% SID M+C with no anti-IL-10 and in Eimeria-challenged broilers fed 0.8% SID M+C with anti-IL-10. In Eimeria-infected broilers, anti-IL-10 increased intestinal luminal IFN-γ and body weight gain only at 0.8% SID M+C. Collectively, anti-IL-10 increased intestinal luminal IFN-γ levels, decreased cecum lesions and restored growth only when fed with adequate amounts of sulfur amino acids. Our findings underscore the importance of providing sufficient essential nutrients to support the anti-IL-10 induced immunity against coccidiosis.

Effects of Protein and Amino Acid Supplementation on Muscle Mass and Strength in a Healthy Population

The objective of this study was to investigate the effect of protein and/or amino acid supplementation on muscle mass and strength in a healthy population. A structured literature search was conducted from database inception up to October 23, 2019, using PubMed and Scopus. Data were collected from randomized controlled trials and weighted mean difference, and its 95% confidence interval was calculated by using a random-effects model. Risk of bias was assessed using the Cochrane tool. Data were included from 46 randomized controlled trials, totaling 2049 participants. Protein but not amino acid supplementation resulted in significant positive effects on muscle mass (weighted mean difference, 0.47 kg; 95% confidence interval, 0.18-0.75 kg; P &lt; .001) and upper body strength. The significant effect of protein supplementation on muscle mass persisted in the subgroups with and without resistance training, in young (&lt;30 years) and older (≥59 years) adults, and across either gender. This review suggests that dietary protein and/or amino acid supplementation may promote muscle mass hypertrophy and/or maintenance, as well as some measures of muscular strength in a healthy population.

Sulfur Amino Acid Supplementation Abrogates Protective Effects of Caloric Restriction for Enhancing Bone Marrow Regrowth Following Ionizing Radiation.

Radiation therapy damages and depletes total bone marrow (BM) cellularity, compromising safety and limiting effective dosing. Aging also strains total BM and BM hematopoietic stem and progenitor cell (HSPC) renewal and function, resulting in multi-system defects. Interventions that preserve BM and BM HSPC homeostasis thus have potential clinical significance. Here, we report that 50% calorie restriction (CR) for 7-days or fasting for 3-days prior to irradiation improved mouse BM regrowth in the days and weeks post irradiation. Specifically, one week of 50% CR ameliorated loss of total BM cellularity post irradiation compared to ad libitum-fed controls. CR-mediated BM protection was abrogated by dietary sulfur amino acid (i.e., cysteine, methionine) supplementation or pharmacological inhibition of sulfur amino acid metabolizing and hydrogen sulfide (H2S) producing enzymes. Up to 2-fold increased proliferative capacity of ex vivo-irradiated BM isolated from food restricted mice relative to control mice indicates cell autonomy of the protective effect. Pretreatment with H2S in vitro was sufficient to preserve proliferative capacity by over 50% compared to non-treated cells in ex vivo-irradiated BM and BM HSPCs. The exogenous addition of H2S inhibited Ten eleven translocation 2 (TET2) activity in vitro, thus providing a potential mechanism of action. Short-term CR or fasting therefore offers BM radioprotection and promotes regrowth in part via altered sulfur amino acid metabolism and H2S generation, with translational implications for radiation treatment and aging.

The Amino Acids Sensing and Utilization in Response to Dietary Aromatic Amino Acid Supplementation in LPS-Induced Inflammation Piglet Model.

Dietary supplementation with aromatic amino acids (AAAs) has been demonstrated to alleviate intestinal inflammation induced by lipopolysaccharide (LPS) in the piglets. But the mechanism of AAA sensing and utilization under inflammatory conditions is not well-understood. The study was conducted with 32 weanling piglets using a 2 × 2 factorial arrangement (diet and LPS challenge) in a randomized complete block design. Piglets were fed as basal diet or the basal diet supplemented with 0.16% tryptophan (Trp), 0.41% phenylalanine (Phe), and 0.22% tyrosine (Tyr) for 21 days. The results showed that LPS treatment significantly reduced the concentrations of cholecystokinin (CCK) and total protein but increased leptin concentration, the activities of alanine transaminase, and aspartate aminotransferase in serum. Dietary supplementation with AAAs significantly increased the serum concentrations of CCK, peptide YY (PYY), and total protein but decreased the blood urea nitrogen. LPS challenge reduced the ileal threonine (Thr) digestibility, as well as serum isoleucine (Ile) and Trp concentrations, but increased the serum concentrations of Phe, Thr, histidine (His), alanine (Ala), cysteine (Cys), and serine (Ser) (P < 0.05). The serum-free amino acid concentrations of His, lysine (Lys), arginine (Arg), Trp, Tyr, Cys, and the digestibilities of His, Lys, Arg, and Cys were significantly increased by feeding AAA diets (P < 0.05). Dietary AAA supplementation significantly increased the serum concentrations of Trp in LPS-challenged piglets (P < 0.05). In the jejunal mucosa, LPS increased the contents of Ala and Cys, and the mRNA expressions of solute carrier (SLC) transporters (i.e., SLC7A11, SLC16A10, SLC38A2, and SLC3A2), but decreased Lys and glutamine (Gln) contents, and SLC1A1 mRNA expression (P < 0.05). In the ileal mucosa, LPS challenge induced increasing in SLC7A11 and SLC38A2 and decreasing in SLC38A9 and SLC36A1 mRNA expressions, AAAs supplementation significantly decreased mucosal amino acid (AA) concentrations of methionine (Met), Arg, Ala, and Tyr, etc. (P < 0.05). And the interaction between AAAs supplementation and LPS challenge significantly altered the expressions of SLC36A1 and SLC38A9 mRNA (P < 0.05). Together, these findings indicated that AAAs supplementation promoted the AAs absorption and utilization in the small intestine of piglets and increased the mRNA expressions of SLC transports to meet the high demands for specific AAs in response to inflammation and immune response.

513 Late-Breaking: Effects of Dietary Protein Content and Crystalline Amino Acid Supplementation Patterns on Gut Health of Weaned Pigs Raised Under Different Sanitary Conditions

Abstract The objective of this experiment was to investigate the effects of dietary crude protein (CP) content and crystalline amino acids (CAA) supplementation patterns on the histomorphology, immune response, and microbial metabolites in weaned pigs under clean (CSC) or unclean sanitary conditions (USC). One hundred forty-four piglets (6.35 ± 0.63 kg BW) were assigned to 1 of 3 diets: a high CP (HCP; 21%) and two low CP (LCP; 18%) diets supplemented with 10 crystalline indispensable amino acids (IAA) to meet all IAA requirements or only 6 IAA (Lys, Met, Thr, Trp, Val, and Ile) to meet IAA requirements except for Leu, His, and Phe. Each treatment had 8 replicates per sanitary condition with 3 pigs per pen. The CSC room was cleaned and washed weekly, whereas the USC room remained unwashed throughout the experiment and had sow manure spread in the pens. Data were analyzed using the MIXED procedure of SAS with orthogonal contrasts. Pigs fed the LCP diets had longer (P &amp;lt; 0.05) jejunal villi and higher villus height to crypt depth ratios than those fed the HCP diet. No significant difference is found in histomorphology between pigs fed LCP diets with different CAA supplementation patterns. Pigs raised under USC had greater (P &amp;lt; 0.05) plasma interleukin (IL)-10 and IL-6 concentrations and reduced (P &amp;lt; 0.05) plasma tumor necrosis factor-alpha concentration. Also, the LCP diets resulted in a greater (P &amp;lt; 0.05) plasma IL-10 concentration. Interactions (P &amp;lt; 0.05) between sanitation and dietary CP content were observed for goblet cell density and acetate and total volatile fatty acids contents in the jejunum. In conclusion, CAA supplementation patterns did not affect gut morphology in weaned pigs. Feeding LCP diets to weaned pigs improved gut morphology and microbial metabolites in jejunum under USC and ameliorated systemic inflammation induced by USC.

Effects of Dietary Fishmeal Replacement by Poultry By-Product Meal and Hydrolyzed Feather Meal on Liver and Intestinal Histomorphology and on Intestinal Microbiota of Gilthead Seabream (Sparus aurata)

The effects on liver and intestinal histomorphology and on intestinal microbiota in gilthead seabream (Sparus aurata) fed diets that contained poultry by-product meal (PBM) and hydrolyzed feather meal (HFM) as fishmeal replacements were studied. Fish fed on a series of isonitrogenous and isoenergetic diets, where fishmeal protein of the control diet (FM diet) was replaced by either PBM or by HFM at 25%, 50% and 100% without amino acid supplementation (PBM25, PBM50, PBM100, HFM25, HFM50 and HFM100 diets) or supplemented with lysine and methionine (PBM25+, PBM50+, HFM25+ and HFM50+ diets). The use of PBM and HFM at 25% fishmeal replacement generated a similar hepatic histomorphology to FM-fed fish, indicating that both land animal proteins are highly digestible at low FM replacement levels. However, 50% and 100% FM replacement levels by either PBM or HFM resulted in pronounced hepatic alterations in fish with the latter causing more severe degradation of the liver. Dietary amino acid supplementation delivered an improved tissue histology signifying their importance at high FM replacement levels. Intestinal microbiota was dominated by Proteobacteria (58.8%) and Actinobacteria (32.4%) in all dietary groups, but no specific pattern was observed among them at any taxonomic level. This finding was probably driven by the high inter-individual variability observed.